These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23925487)

  • 1. Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.
    Lokamani I; Looi ML; Md Ali SA; Mohd Dali AZ; Ahmad Annuar MA; Jamal R
    Pathol Oncol Res; 2014 Jan; 20(1):119-29. PubMed ID: 23925487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
    Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
    Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of plasma biomarkers in uterine leiomyoma.
    Lin CP; Chen YW; Liu WH; Chou HC; Chang YP; Lin ST; Li JM; Jian SF; Lee YR; Chan HL
    Mol Biosyst; 2012 Apr; 8(4):1136-45. PubMed ID: 22193648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
    Looi ML; Karsani SA; Rahman MA; Dali AZ; Ali SA; Ngah WZ; Yusof YA
    J Biosci; 2009 Dec; 34(6):917-25. PubMed ID: 20093745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma.
    Tian WD; Li JZ; Hu SW; Peng XW; Li G; Liu X; Chen HH; Xu X; Li XP
    Int J Clin Exp Pathol; 2015; 8(8):9021-31. PubMed ID: 26464644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.
    Chai YD; Zhang L; Yang Y; Su T; Charugundla P; Ai J; Messadi D; Wong DT; Hu S
    Head Neck; 2016 Jan; 38(1):118-25. PubMed ID: 25223295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).
    Kondo T
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):2-8. PubMed ID: 30392560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.
    Junker H; Venz S; Zimmermann U; Thiele A; Scharf C; Walther R
    PLoS One; 2011; 6(7):e21867. PubMed ID: 21760917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics.
    Gajbhiye A; Dabhi R; Taunk K; Vannuruswamy G; RoyChoudhury S; Adhav R; Seal S; Mane A; Bayatigeri S; Santra MK; Chaudhury K; Rapole S
    Proteomics; 2016 Sep; 16(17):2403-18. PubMed ID: 27324523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer.
    Tsai MH; Wu CC; Peng PH; Liang Y; Hsiao YC; Chien KY; Chen JT; Lin SJ; Tang RP; Hsieh LL; Yu JS
    J Mol Med (Berl); 2012 Feb; 90(2):187-200. PubMed ID: 21997591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
    Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
    Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma.
    Poli G; Ceni E; Armignacco R; Ercolino T; Canu L; Baroni G; Nesi G; Galli A; Mannelli M; Luconi M
    Oncotarget; 2015 Mar; 6(8):5695-706. PubMed ID: 25691058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of serum biomakers of osteosarcoma by proteomic profiling].
    Shen JN; Jin S; Wang J; Huang G; Yin JQ; Guo QC; Li HM; Liu W; Liu SJ; Li MT
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):519-22. PubMed ID: 19062719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome.
    Kankaya D; Kiremitci S; Tulunay O; Baltaci S
    Pathol Res Pract; 2015 Jul; 211(7):505-12. PubMed ID: 25908108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of plasma from Holstein cows testing positive for Mycobacterium avium subsp. paratuberculosis (MAP).
    You Q; Verschoor CP; Pant SD; Macri J; Kirby GM; Karrow NA
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):243-51. PubMed ID: 22633222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.
    Han ZD; Zhang YQ; He HC; Dai QS; Qin GQ; Chen JH; Cai C; Fu X; Bi XC; Zhu JG; Liao DJ; Lu XP; Mo ZY; Zhu YP; Zhong WD
    Med Oncol; 2012 Dec; 29(4):2877-88. PubMed ID: 22215415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.